ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,269Medicare Part D Prescriptions Filled, Including Refills

Rank: 227 out of 617

$314K Total Retail Price of All Prescriptions

Rank: 231 out of 617

348 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 348 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 348 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 4,479 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
OMEPRAZOLE 312 187 1 3
LEVOTHYROXINE SODIUM 258 173 2 1
WARFARIN SODIUM 227 203 3 7
FUROSEMIDE 204 161 4 4
LISINOPRIL 186 169 5 5
HYDROCODONE-ACETAMINOPHEN 166 92 S3 6 8
METOPROLOL TARTRATE 146 110 7 11
ATENOLOL 144 102 8 17
POTASSIUM CHLORIDE 135 116 9 10
SIMVASTATIN 134 99 10 2
POLYETHYLENE GLYCOL 3350 125 50 11 32
AMLODIPINE BESYLATE 113 95 12 6
PRAVASTATIN SODIUM 106 69 13 21
HYDROCHLOROTHIAZIDE 104 94 14 13
SERTRALINE HCL 99 86 15 20
METOPROLOL SUCCINATE 97 63 16 12
GABAPENTIN 93 73 17 16
METFORMIN HCL 87 60 18 9
DONEPEZIL HCL 82 82 19 30
BENAZEPRIL HCL 79 74 20 44
PANTOPRAZOLE SODIUM 65 32 21 37
ZOLPIDEM TARTRATE 65 47 21 23
CITALOPRAM HBR 63 59 23 18
MELOXICAM 58 44 24 24
LANTUS 57 50 25 39
ALENDRONATE SODIUM 56 48 26 25
TAMSULOSIN HCL 55 55 27 26
ALLOPURINOL 55 43 27 27
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 33 29 91
RANITIDINE HCL 52 0 30 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.